News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center
IU Simon Comprehensive Cancer Center/LinkedIn
Jan 7, 2025, 14:28

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center shared a post on LinkedIn about a recent paper by Michael Weisman et al. published in International Journal of Radiation Oncology, Biology, Physics:

“Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer”

Authors: Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser Hanna, Sandra Althouse, Tim Lautenschlaeger.

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC - IU Simon Comprehensive Cancer Center

“Gain valuable insights from a new article published in the International Journal of Radiation Oncology, Biology, Physics by the cancer center’s Greg Durm, MD, Misty D. Shields, MD, PhD, Nasser H. Hanna, MD, Tim Lautenschlaeger, MD, and colleagues.”

More posts featuring IU Simon Comprehensive Cancer Center.

cancer Greg Durm ipilimumab IU Simon Comprehensive Cancer Center Michael Weisman Misty Dawn Shields Nasser Hanna nivolumab non small cell lung cancer NSCLC OncoDaily Oncology Sandra Althouse Tim Lautenschlaeger
Special Coverage
Insight
May 9, 2025, 14:48
Exploring PD-L1 in Oral Cavity Cancers: Insights from a Tertiary Care Audit in India - IJSO
Blog
May 9, 2025, 14:34
Maria Concetta La Milia: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy at ESTRO2025
Blog
May 9, 2025, 14:19
Josh Thomas Georgy Highlights DESTINY-Breast11 Results in High-Risk HER2+ Early Breast Cancer
Blog
May 9, 2025, 14:18
Half of Patients Diagnosed With Cancer in 2023 Had a History of Smoking - CRI
Blog
May 9, 2025, 14:08
Aligning Incentives for Value-Based Success: Building Sustainable Oncology Partnerships - CancerX
Blog
May 9, 2025, 14:06
Childhood Cancer at Survivor’s Week 2025: A Celebration of Strength and New Beginnings
Blog
May 9, 2025, 14:01
Meet the ASCO25 Featured Voices
Blog
May 9, 2025, 13:59
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support
Insight
May 9, 2025, 13:55
FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot
Blog
May 9, 2025, 13:49
Fernando Goldsztein: A Time to Raise Awareness about Brain Tumors
Blog
May 9, 2025, 13:46
Small Cell Lung Cancer Progress: Insights from LUNGevity's Executive Director
Blog
May 9, 2025, 13:37
Helena Linardou: Exciting afternoon at the 2025 AI for Oncology Congress